Citation Tools
PDFDrug information (i. anti-infectives, ii. cytostatics, iii. others)
DGI-042 Hypomagnesemia as a Possible Marker of Efficacy in Patients with Head and Neck Carcinoma in First-Line Treatment with Cetuximab
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- DGI-042 Hypomagnesemia as a Possible Marker of Efficacy in Patients with Head and Neck Carcinoma in First-Line Treatment with Cetuximab